| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BeiGene, Ltd. | Director | Ordinary Shares | 19,136 | $4,686,406 | $244.90 | 21 May 2025 | Direct |
| Organon & Co. | Director | Phantom Stock | 63,054 | $633,063 | $10.04 | 13 Jun 2025 | Direct |
| NEUROCRINE BIOSCIENCES INC | Director | Common Stock | 2,429 | $256,891 | $105.76 | 22 May 2025 | Direct |
| NEUROCRINE BIOSCIENCES INC | Director | Non-Qualified Stock Option | 3,305 | $219,475 | $73.60 | 21 May 2025 | Direct |
| NEUROCRINE BIOSCIENCES INC | Director | Restricted Stock Unit | 1,435 | $203,629 | $141.90 | 22 May 2024 | Direct |
| PRECISION BIOSCIENCES INC | Director | Stock Option (Right to Buy) | 32,800 | 10 May 2021 | Direct | ||
| BeiGene, Ltd. | Director | Share Option (Right to Buy) | 22,750 | 21 May 2025 | Direct | ||
| SUTRO BIOPHARMA, INC. | Director | Stock Option (right to buy) | 18,500 | 06 Jun 2022 | Direct | ||
| Septerna, Inc. | Director | Stock Option (Right to Buy) | 16,623 | 17 Jun 2025 | Direct | ||
| Mirati Therapeutics, Inc. | Director | Common Stock | 0 | $59.02 | 23 Jan 2024 | Direct | |
| Mirati Therapeutics, Inc. | Director | Option to Purchase Common Stock | 0 | 23 Jan 2024 | Direct | ||
| NEUROCRINE BIOSCIENCES INC | Director | Restricted Stock Unit | 0 | 22 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SEPN | Septerna, Inc. | 17 Jun 2025 | 1 | $0 | 4 | Director | 20 Jun 2025, 18:44 |
| OGN | Organon & Co. | 13 Jun 2025 | 1 | +$240,000 | 4 | Director | 16 Jun 2025, 17:34 |
| BGNE | BeiGene, Ltd. | 21 May 2025 | 2 | $0 | 4 | Director | 22 May 2025, 19:47 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 21 May 2025 | 4 | $0 | 4 | Director | 22 May 2025, 17:28 |
| SEPN | Septerna, Inc. | 24 Oct 2024 | 0 | $0 | 3 | Director | 24 Oct 2024, 21:28 |
| BGNE | BeiGene, Ltd. | 30 Sep 2024 | 2 | $0 | 4 | Director | 02 Oct 2024, 19:21 |
| BGNE | BeiGene, Ltd. | 27 Sep 2024 | 0 | $0 | 3 | Director | 02 Oct 2024, 19:16 |
| OGN | Organon & Co. | 07 Jun 2024 | 1 | +$200,000 | 4 | Director | 11 Jun 2024, 15:17 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 22 May 2024 | 2 | $0 | 4 | Director | 23 May 2024, 18:34 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 17 May 2024 | 3 | -$156,943 | 4 | Director | 21 May 2024, 17:35 |
| MRTX | Mirati Therapeutics, Inc. | 23 Jan 2024 | 4 | $0 | 4 | Director | 23 Jan 2024, 20:38 |
| MRTX | Mirati Therapeutics, Inc. | 29 Dec 2023 | 1 | +$399,970 | 4 | Director | 03 Jan 2024, 18:24 |
| OGN | Organon & Co. | 09 Jun 2023 | 1 | +$200,005 | 4 | Director | 13 Jun 2023, 17:00 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 17 May 2023 | 2 | $0 | 4 | Director | 19 May 2023, 17:22 |
| MRTX | Mirati Therapeutics, Inc. | 20 Jan 2023 | 2 | $0 | 4 | Director | 24 Jan 2023, 15:03 |
| OGN | Organon & Co. | 10 Jun 2022 | 1 | +$199,994 | 4 | Director | 14 Jun 2022, 19:42 |
| STRO | SUTRO BIOPHARMA, INC. | 06 Jun 2022 | 1 | $0 | 4 | Director | 08 Jun 2022, 19:10 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 18 May 2022 | 1 | $0 | 4 | Director | 20 May 2022, 16:16 |
| MRTX | Mirati Therapeutics, Inc. | 14 Jan 2022 | 2 | $0 | 4 | Director | 18 Jan 2022, 17:17 |
| OGN | Organon & Co. | 04 Jun 2021 | 1 | +$326,649 | 4 | Director | 08 Jun 2021, 20:31 |
| STRO | SUTRO BIOPHARMA, INC. | 03 Jun 2021 | 1 | $0 | 4 | Director | 07 Jun 2021, 17:07 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 19 May 2021 | 1 | $0 | 4 | Director | 20 May 2021, 16:12 |
| OGN | Organon & Co. | 14 May 2021 | 0 | $0 | 3 | Director | 17 May 2021, 16:10 |
| DTIL | PRECISION BIOSCIENCES INC | 10 May 2021 | 1 | $0 | 4 | Director | 12 May 2021, 16:09 |